Personal profile
Headline
ASSISTANT PROFESSOR, DIRECTOR | Drug Development and Nanomedicine Core
Biography
Dr. Satish Rojekar is an Assistant Professor and Director of the Drug Development and Nanomedicine Core at the Icahn School of Medicine at Mount Sinai. With a Ph.D. in Pharmaceutics, his research focuses on biotherapeutics, nanomedicine, microneedle drug delivery, and pharmaceutical technology, aiming to improve treatments for chronic disorders like obesity, osteoporosis, Alzheimer's, and HIV.
He has expertise in formulation development, CMC, preclinical development, IND-enabling research, and biophysical characterization. Dr. Rojekar has advanced drug delivery systems such as monoclonal antibody formulations and lipid nanoparticles for gene delivery. He is also a scientific leader, mentor, and editor for international journals and holds GLP and GCP certifications. His work has resulted in patents, publications, and collaborations to revolutionize drug delivery technologies.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
From discovery to therapeutic development of monoclonal antibodies
Rojekar, S., Gholap, A. D., Pallapati, A. R., Latif, R., Angsantikul, P., Kommineni, N., Sultana, F., Macdonald, A., Vasilyeva, D., Sims, S., Parte, S., Haeck, C., Pandey, R., Gimenez-Roig, J., Gumerova, A., Cheliadinova, U., Pevnev, G., Burganova, G., Tumoglu, Z. & Mansoori, M. & 13 others, , 10 Aug 2026, In: Journal of Controlled Release. 396, 115034.Research output: Contribution to journal › Review article › peer-review
-
Fshr gene depletion prevents recognition memory loss, fat accrual and bone loss in Alzheimer’s mice
Cheliadinova, U., Sims, S., Korkmaz, F., Vasilyeva, D., Laurencin, V., Gimenez-Roig, J., Pevnev, G., Burganova, G., Tumoglu, Z., Parte, S., Sultana, F., Pallapati, A. R., Rojekar, S., Macdonald, A., Hutchison, S., Soussan, A., Liu, A., Wei, Y., Moldavski, O. & Gumerova, A. & 9 others, , May 2026, In: Molecular Psychiatry. 31, 5, p. 2645-2651 7 p.Research output: Contribution to journal › Article › peer-review
-
Latest Advancements in Biotherapeutics
Rojekar, S., 2026, In: Current Pharmaceutical Biotechnology. 27, 5, p. 523-526 4 p.Research output: Contribution to journal › Editorial
-
Microneedle Technologies for Drug Delivery: Innovations, Applications, and Commercial Challenges
Gattu, K., Godugu, D., Jain, H., Jadhav, K., Cho, H. & Rojekar, S., Jan 2026, In: Micromachines. 17, 1, 102.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Nanobody Therapeutics in Alzheimer’s Disease: From Molecular Mechanisms to Translational Approaches
Godugu, D., Gattu, K., Suri, P., Daartey, A. B., Jadhav, K. & Rojekar, S., Feb 2026, In: Antibodies. 15, 1, 1.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations
Press/Media
-
Studies Conducted at Icahn School of Medicine at Mount Sinai on Monoclonal Antibodies Recently Reported (From discovery to therapeutic development of monoclonal antibodies)
Latif, R., Pandey, R., Sultana, F., Rojekar, S., Pallapati, A. R. & Gumerova, A.
29/05/26
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai Update Current Data on Memory Disorders (Gene-dose-dependent Reduction of fshr Expression Improves Spatial Memory Deficits In Alzheimer's Mice)
Lizneva, D., Yuen, T., Zaidi, M., Vitaly, R., Rojekar, S., Pallapati, A. R., Frolinger, T., Sultana, F., Gumerova, A. & Goosens, K.
10/12/24
1 item of Media coverage
Press/Media